JPWO2022256554A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022256554A5 JPWO2022256554A5 JP2023574858A JP2023574858A JPWO2022256554A5 JP WO2022256554 A5 JPWO2022256554 A5 JP WO2022256554A5 JP 2023574858 A JP2023574858 A JP 2023574858A JP 2023574858 A JP2023574858 A JP 2023574858A JP WO2022256554 A5 JPWO2022256554 A5 JP WO2022256554A5
- Authority
- JP
- Japan
- Prior art keywords
- ethyl
- indol
- fluoro
- amine
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163195943P | 2021-06-02 | 2021-06-02 | |
| US63/195,943 | 2021-06-02 | ||
| US202163288313P | 2021-12-10 | 2021-12-10 | |
| US63/288,313 | 2021-12-10 | ||
| PCT/US2022/032000 WO2022256554A1 (en) | 2021-06-02 | 2022-06-02 | Fluorinated tryptamine compounds, analogues thereof, and methods using same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024523822A JP2024523822A (ja) | 2024-07-02 |
| JPWO2022256554A5 true JPWO2022256554A5 (https=) | 2025-06-03 |
| JP2024523822A5 JP2024523822A5 (https=) | 2025-06-03 |
Family
ID=84324579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023574858A Pending JP2024523822A (ja) | 2021-06-02 | 2022-06-02 | フッ素化トリプタミン化合物、その類似体、及びそれを使用する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240286998A1 (https=) |
| EP (1) | EP4347559A4 (https=) |
| JP (1) | JP2024523822A (https=) |
| KR (1) | KR20240017363A (https=) |
| AU (1) | AU2022287013A1 (https=) |
| BR (1) | BR112023025340A2 (https=) |
| CA (1) | CA3220850A1 (https=) |
| CO (1) | CO2023018652A2 (https=) |
| IL (1) | IL308944A (https=) |
| MX (1) | MX2023014437A (https=) |
| WO (1) | WO2022256554A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL326048A (en) | 2021-09-03 | 2026-03-01 | Alexander Shulgin Res Institute Inc | Asymmetric allyl tryptamines |
| WO2023147424A1 (en) * | 2022-01-27 | 2023-08-03 | Terran Biosciences, Inc. | Salts and solid forms of n-ethyl-2-(5-fluoro-1h-indol-3-yl)- n-methylethan-1-amine |
| US12157722B1 (en) * | 2023-08-03 | 2024-12-03 | Gilgamesh Pharmaceuticals, Inc. | Crystalline hydrochloride salts of N-ethyl-2-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine |
| US12129234B1 (en) | 2023-08-03 | 2024-10-29 | Gilgamesh Pharmaceuticals, Inc. | Crystalline salts of N-ethyl-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amine |
| CN121866243A (zh) * | 2023-09-07 | 2026-04-14 | 耶路撒冷希伯来大学伊森姆研究发展有限公司 | 致幻化合物、其制备方法及其用途 |
| WO2025104491A1 (en) * | 2023-11-14 | 2025-05-22 | Mindset Pharma Inc. | Indole derivatives as serotonergic agents useful for the treatment of disorders related thereto |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE232201T1 (de) * | 1995-06-06 | 2003-02-15 | Schering Corp | Substituierte benzokondensierte heterocyclen als neurokinin antagonisten |
| DE19615232A1 (de) * | 1996-04-18 | 1997-10-23 | Merck Patent Gmbh | Neue Carbamoylderivate und deren Verwendung als 5-HT ¶1¶¶A¶-Antagonisten |
| US6100291A (en) * | 1998-03-16 | 2000-08-08 | Allelix Biopharmaceuticals Inc. | Pyrrolidine-indole compounds having 5-HT6 affinity |
| AR021509A1 (es) * | 1998-12-08 | 2002-07-24 | Lundbeck & Co As H | Derivados de benzofurano, su preparacion y uso |
| US6800637B2 (en) * | 2002-09-12 | 2004-10-05 | Wyeth | Antidepressant indolealkyl derivatives of heterocycle-fused benzodioxan methylamines |
| CA3052974A1 (en) * | 2017-02-09 | 2018-08-16 | CaaMTech, LLC | Compositions and methods comprising a psilocybin derivative |
| WO2019222552A1 (en) * | 2018-05-16 | 2019-11-21 | University Of Florida Research Foundation | Methods and compositions for substituted 2,5-diketopiperazine analogs |
| GB201907871D0 (en) * | 2019-06-03 | 2019-07-17 | Small Pharma Ltd | Therapeutic compositions |
| MX2022009528A (es) * | 2020-02-04 | 2022-11-14 | Mindset Pharma Inc | Derivados de 3-pirrolidina-indol como agentes psicodélicos serotoninérgicos para el tratamiento de trastornos del snc. |
| KR20230124103A (ko) * | 2020-02-18 | 2023-08-24 | 길가메쉬 파마슈티컬스, 인코포레이티드 | 기분 장애 치료에 사용되기 위한 특이적 트립타민 |
| MX2023002557A (es) * | 2020-09-01 | 2023-05-29 | Enveric Biosciences Canada Inc | Derivados de psilocibina halogenada y metodos de uso. |
| CA3192617A1 (en) * | 2020-09-20 | 2022-03-24 | Matthew BAGGOTT | Advantageous tryptamine compositions for mental disorders or enhancement |
| CN116917305A (zh) * | 2020-12-07 | 2023-10-20 | 明德赛特制药公司 | 用于治疗cns病症的作为血清素能剂的3-环状胺-吲哚衍生物 |
-
2022
- 2022-06-02 EP EP22816868.8A patent/EP4347559A4/en active Pending
- 2022-06-02 MX MX2023014437A patent/MX2023014437A/es unknown
- 2022-06-02 BR BR112023025340A patent/BR112023025340A2/pt unknown
- 2022-06-02 WO PCT/US2022/032000 patent/WO2022256554A1/en not_active Ceased
- 2022-06-02 CA CA3220850A patent/CA3220850A1/en active Pending
- 2022-06-02 JP JP2023574858A patent/JP2024523822A/ja active Pending
- 2022-06-02 AU AU2022287013A patent/AU2022287013A1/en active Pending
- 2022-06-02 KR KR1020237044652A patent/KR20240017363A/ko active Pending
- 2022-06-02 IL IL308944A patent/IL308944A/en unknown
- 2022-06-02 US US18/565,565 patent/US20240286998A1/en active Pending
-
2023
- 2023-12-29 CO CONC2023/0018652A patent/CO2023018652A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020183410A5 (https=) | ||
| KR100558506B1 (ko) | 과도한 물질 ｐ에 의해 야기된 문제점을 치료하기 위한약물 제조에 사용되는 아릴(또는헤테로아릴)아졸일카르비놀 유도체의 용도 | |
| JP2009526821A (ja) | 注意欠陥多動性障害治療用の新規な医薬組成物 | |
| JP2011510014A5 (https=) | ||
| JP2008531714A (ja) | 不安障害の治療用及び／又は予防用の医薬組成物 | |
| JP2009504763A5 (https=) | ||
| JP2021512098A5 (https=) | ||
| JP2011527683A5 (https=) | ||
| JP2007533686A5 (https=) | ||
| JP2008538741A (ja) | 鬱病の治療用及び／又は予防用の医薬組成物 | |
| JP2008110984A5 (https=) | ||
| MA31311B1 (fr) | Dérivés d'indazole substitués par oxadiazole, destinés à être utilisés comme agonistes de la sphingosine 1-phosphate (s1p) | |
| JP2011500758A5 (https=) | ||
| JP2013532727A5 (https=) | ||
| JP2008540554A5 (https=) | ||
| CN103402514A (zh) | 用于治疗运动障碍的血清素受体激动剂组合物 | |
| FR2829027A1 (fr) | Association avec un antagoniste du recepteur cb1, les compositions pharmaceutiques les contenant et leur utilisation pour le traitement de la maladie de parkinson | |
| JP2018108998A (ja) | Ｐｉ−３キナーゼ阻害剤の投与レジメン | |
| SG172735A1 (en) | Method of modulating neurite outgrowth by the use of a galanin-3 receptor antagonist | |
| JPWO2022256554A5 (https=) | ||
| JP2019525900A5 (https=) | ||
| JP2016538306A5 (https=) | ||
| JP2006513222A5 (https=) | ||
| US6562858B2 (en) | Method for treating depression | |
| JP2007533745A (ja) | 脂溶性のシリコン置換シクロオキシゲナーゼ−２選択的非ステロイド性抗炎症薬及び誘導体の医薬組成物及び使用方法 |